Compare Nebius Group NV (NBIS) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nebius Group NV vs Novavax Inc — how do they compare? Nebius Group NV trades at $219.22 (market cap $46.37B), while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: Nebius Group NV is far larger — about 35.7× Novavax Inc's market cap, and Nebius Group NV is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NBIS | NVAX | |
|---|---|---|
Market Cap | $46.37B | $1.30B |
Sector | Technology | Health |
52-Week High | $286.69 | $11.19 |
52-Week Low | $50.40 | $6.22 |
Enterprise Value | $46.56B | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nebius Group NV
Nebius Group N.V. is a technology company specializing in AI, machine learning, and cloud computing solutions. The company provides a range of enterprise-level cloud services, including large-scale data processing, advanced analytics, and AI model development and deployment. Nebius Group focuses on serving businesses that require high-performance, scalable, and secure infrastructure to handle complex computational tasks and accelerate their digital transformation.
Read more on NBIS →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
